K26 patent family

GPTKB entity

Properties (58)
Predicate Object
gptkbp:instanceOf patent family
gptkbp:assignee Company XYZ
gptkbp:citedBy 10 other patents
gptkbp:contains claims regarding formulations for metabolic disorders
claims regarding active ingredients
claims regarding administration routes
claims regarding combination therapies
claims regarding delivery systems
claims regarding dosage
claims regarding efficacy
claims regarding formulation
claims regarding formulations for acute conditions
claims regarding formulations for allergies
claims regarding formulations for cancer
claims regarding formulations for children
claims regarding formulations for diagnostics
claims regarding formulations for elderly
claims regarding formulations for inflammation
claims regarding formulations for pain management
claims regarding formulations for rare diseases
claims regarding formulations for vaccines
claims regarding manufacturing process
claims regarding patient populations
claims regarding side effects
claims regarding stability
claims regarding therapeutic uses
claims regarding formulations for gastrointestinal diseases
claims regarding formulations for hormonal disorders
claims regarding formulations for neurological disorders
claims regarding formulations for autoimmune diseases
claims regarding formulations for cardiovascular diseases
claims regarding formulations for respiratory diseases
claims regarding formulations for psychiatric disorders
claims regarding formulations for chronic conditions
claims regarding formulations for specific diseases
claims regarding formulations for dermatological conditions
claims regarding formulations for infectious diseases
gptkbp:covers methods of treatment
pharmaceutical compositions
gptkbp:expirationDate 2030-05-01
gptkbp:filedIn gptkb:Japan
gptkb:United_States
Europe
gptkbp:hasLegalStatus pending
expired
granted
https://www.w3.org/2000/01/rdf-schema#label K26 patent family
gptkbp:includes K26A patent
K26B patent
gptkbp:inventor gptkb:John_Doe
Jane_Smith
gptkbp:priorityDate 2010-05-01
gptkbp:relatedTo K26 patent
K26A1 patent
K26B1_patent
gptkbp:status active
gptkbp:technicalField biotechnology
pharmaceuticals